Industries > Pharma > Global Sports Medicine Market Report 2019-2029

Global Sports Medicine Market Report 2019-2029

Analysis by Application (Knees, Shoulders, Ankle and Foot, Back and Spine, Elbow and Wrist, Hip, Others), by Product (Body Reconstruction & Repair, Body Support & Recovery, Body Monitoring and Evaluation, Accessories), Company and Country Analysis and Forecasts

PAGES: 199
PRODUCT CODE: PHA0476
SUBMARKET: Therapeutic Drugs

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0476 Categories: , Tag:

Market Definition:
• Sports medicines are the medicines which are used for physical treatment and prevention of injuries which are cost by sports or exercise. The increasing sports activities across the globe are increasing the demand for the sports medicine to reduce the risk during the event or tournaments. The global sports medicine market is expected to grow with a CAGR of 7.1% during the forecast period.

Market Overview and Trends
• As per the sports injury Stanford children health statistics, every year in US, about 30 million kids and teenagers participate in some form of organized sports or outdoor activities and yearly, more than 3.5 million injuries occur in the US, which is increasing the demand for sports medicine.
• According to National Safety Council (NSC) data, exercise and use of exercise equipment in the U.S. had caused around 526,000 injuries during the year 2017. Additionally, the increasing number of people choosing sports as career as well as growing trend towards healthy lifestyle has demand for sports medicine over the coming years.
• Moreover, the increasing prevalence of chronic conditions such as cardiovascular diseases and obesity and awareness through various healthcare campaigns has encouraged individuals to adopt healthy lifestyle leading to escalated participation in sports activities.

Market Dynamics:

Factors Influencing the Market Growth:
• Rising incidence of sports injuries
• Consistent innovation of new products and treatment modalities

Factors Restraining the Market Growth:
• High Cost of Implants and Devices

Market Segmentation 2019-2029:

Application
• Knees Market, 2019-2029
• Shoulders Market, 2019-2029
• Ankle and Foot Market, 2019-2029
• Back and Spine Market, 2019-2029
• Elbow and Wrist Market, 2019-2029
• Hip Market, 2019-2029
• Others Market, 2019-2029

Product
• Body Reconstruction & Repair Market, 2019-2029
• Body Support & Recovery Market, 2019-2029
• Body Monitoring and Evaluation Market, 2019-2029
• Accessories Market, 2019-2029

Geographic breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• Middle East Market, 2019-2029
• Africa Market, 2019-2029

Competitive Analysis:
• The key players in the market are focusing on organic and inorganic strategies. For instance, the companies are focusing on partnership and acquisition for new product development and to strengthen their position in the market.
• In February 2017, Smith & Nephew PLC entered into an agreement with Leaf Healthcare, a California-based developer to offers a unique wireless patient monitoring system for injury prevention.
• The North America sports medicine market held more than 43.6% regional share of the global sports medicine industry in 2018. Moreover, increasing number of sports medical centers, increasing participation of people in sports and physical activity, increasing investment in development of sports medicines is expected to drive the North America sports medicine market during the forecast period

Major Market Players:
Arthrex, Inc,Smith & Nephew PLC ,DepuySynthes Companies, Stryker Corporation, Breg, Inc., Conmed Corporation, Zimmer Biomet Holdings, Inc., DJO Global, Inc., Mueller Sports Medicine, Inc., Wright Medical Group N.V., RTI Surgical Holdings, Inc., Performance Health International Limited, Bauerfeind AG, Medtronic PLC, KARL STORZ GmbH & Co. Kg., Tornier N.V., Otto Bock Healthcare, Johnson & Johnson, GE Healthcare, Japan MDM, Inc., Ossur Corporate, Cramer Products, Inc.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Sports Medicine Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Sports Medicine Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Categories